Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Holaday

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
Regulatory Peptides|October 1, 1983
Thyrotropin releasing hormone: autonomic effects upon cardiorespiratory function in endotoxic shockJ W Holaday, A I Faden
NIDA Research Monograph|January 1, 1986
Dynorphin A (1-13): in vivo opioid antagonist actions and non-opioid anticonvulsant effects in the rat flurothyl testF C Tortella, J W Holaday
Life Sciences|July 26, 1982
Naloxone or TRH fails to improve neurologic deficits in gerbil models of "stroke"J W Holaday, R J D'Amato
Advances in Shock Research|January 1, 1983
Spinal shock and injury: experimental therapeutic approachesJ W Holaday, A I Faden
Science (New York, N.Y.)|November 5, 1982
Naloxone and ischemic neurologic deficits in the gerbil: is there an effect?J W Holaday, R J D'Amato
Brain Research|November 16, 1979
The opiate antagonist naloxone modifies the effects of electroconvulsive shock (ECS) on respiration, blood pressure and heart rateG L Belenky, J W Holaday
Science (New York, N.Y.)|July 20, 1979
Opiate antagonists: a role in the treatment of hypovolemic shockA I Faden, J W Holaday
Advances in Biochemical Psychopharmacology|January 1, 1981
Naloxone reverses the pathophysiology of shock through an antagonism of endorphin systemsJ W Holaday, A I Faden
Advances in Biochemical Psychopharmacology|January 1, 1981
A role for endorphins in the pathophysiology of spinal cord injuryA I Faden, J W Holaday
Life Sciences|August 10, 1981
Repeated electroconvulsive shock (ECS) and morphine tolerance: demonstration of cross-sensitivity in the ratG L Belenky, J W Holaday
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
Regulatory Peptides|October 1, 1983
Thyrotropin releasing hormone: autonomic effects upon cardiorespiratory function in endotoxic shockJ W Holaday, A I Faden
NIDA Research Monograph|January 1, 1986
Dynorphin A (1-13): in vivo opioid antagonist actions and non-opioid anticonvulsant effects in the rat flurothyl testF C Tortella, J W Holaday
Life Sciences|July 26, 1982
Naloxone or TRH fails to improve neurologic deficits in gerbil models of "stroke"J W Holaday, R J D'Amato
Advances in Shock Research|January 1, 1983
Spinal shock and injury: experimental therapeutic approachesJ W Holaday, A I Faden
Science (New York, N.Y.)|November 5, 1982
Naloxone and ischemic neurologic deficits in the gerbil: is there an effect?J W Holaday, R J D'Amato
Brain Research|November 16, 1979
The opiate antagonist naloxone modifies the effects of electroconvulsive shock (ECS) on respiration, blood pressure and heart rateG L Belenky, J W Holaday
Science (New York, N.Y.)|July 20, 1979
Opiate antagonists: a role in the treatment of hypovolemic shockA I Faden, J W Holaday
Advances in Biochemical Psychopharmacology|January 1, 1981
Naloxone reverses the pathophysiology of shock through an antagonism of endorphin systemsJ W Holaday, A I Faden
Advances in Biochemical Psychopharmacology|January 1, 1981
A role for endorphins in the pathophysiology of spinal cord injuryA I Faden, J W Holaday
Life Sciences|August 10, 1981
Repeated electroconvulsive shock (ECS) and morphine tolerance: demonstration of cross-sensitivity in the ratG L Belenky, J W Holaday
Pageof 15